Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
101.00
+8.80 (9.54%)
Apr 28, 2026, 1:30 PM CST
65.03% (1Y)
| Market Cap | 143.50B |
| Revenue (ttm) | 38.04M |
| Net Income (ttm) | -284.11M |
| Shares Out | 1.56B |
| EPS (ttm) | -0.18 |
| PE Ratio | n/a |
| Forward PE | 29.62 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,134,918 |
| Average Volume | 15,025,387 |
| Open | 93.50 |
| Previous Close | 92.20 |
| Day's Range | 92.90 - 101.00 |
| 52-Week Range | 61.70 - 277.00 |
| Beta | 1.37 |
| RSI | 43.94 |
| Earnings Date | May 5, 2026 |